Literature DB >> 24262691

Urticaria: impact on quality of life and economic cost.

Brigid F O'Donnell1.   

Abstract

Patients with urticaria suffer itch, swellings, fatigue caused by sleep disturbance and the side effects of medication, and disruption of many facets of their lives. Much progress has been made in formally evaluating the degree of quality-of-life (QoL) impairment suffered by patients with urticaria. This review focuses on QoL in chronic urticaria (>6 weeks duration) and examines QoL measures, including the chronic urticaria-quality of life questionnaire (CU-Q2oL). Patients with urticaria have difficulty identifying and coping with their emotions. The psychiatric comorbidity and the financial burden on the patient and society because of chronic urticaria, is also examined.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angioedema; Cost; Health-related quality of life; Patient-reported outcomes; Psychiatric comorbidity; Urticaria

Mesh:

Year:  2014        PMID: 24262691     DOI: 10.1016/j.iac.2013.09.011

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  20 in total

1.  The association of chronic spontaneous urticaria (CSU) with anxiety and depression: a nationwide cohort study.

Authors:  Dana Tzur Bitan; Daniella Berzin; Arnon Cohen
Journal:  Arch Dermatol Res       Date:  2020-04-08       Impact factor: 3.017

2.  Resource use and costs in an insured population of patients with chronic idiopathic/spontaneous urticaria.

Authors:  Michael S Broder; Karina Raimundo; Evgeniya Antonova; Eunice Chang
Journal:  Am J Clin Dermatol       Date:  2015-08       Impact factor: 7.403

Review 3.  Chronic urticaria in adults: state-of-the-art in the new millennium.

Authors:  Paulo Ricardo Criado; Roberta Facchini Jardim Criado; Celina Wakisaka Maruta; Vitor Manoel Silva dos Reis
Journal:  An Bras Dermatol       Date:  2015 Jan-Feb       Impact factor: 1.896

4.  Economic burden of refractory chronic spontaneous urticaria on Kuwait's health system.

Authors:  Mona Al-Ahmad; Maryam S Alowayesh; Norman V Carroll
Journal:  Clinicoecon Outcomes Res       Date:  2016-05-10

5.  The Impact of Chronic Urticaria from the Patient's Perspective: A Survey in Five European Countries.

Authors:  Maria-Magdalena Balp; Jeffrey Vietri; Haijun Tian; Gina Isherwood
Journal:  Patient       Date:  2015-12       Impact factor: 3.883

Review 6.  The challenges of chronic urticaria part 1: Epidemiology, immunopathogenesis, comorbidities, quality of life, and management.

Authors:  Mario Sánchez-Borges; Ignacio J Ansotegui; Ilaria Baiardini; Jonathan Bernstein; Giorgio Walter Canonica; Motohiro Ebisawa; Maximiliano Gomez; Sandra Nora Gonzalez-Diaz; Bryan Martin; Mário Morais-Almeida; Jose Antonio Ortega Martell
Journal:  World Allergy Organ J       Date:  2021-06-01       Impact factor: 4.084

7.  Acupuncture for patients with chronic urticaria: a systematic review protocol.

Authors:  Qin Yao; Yongming Ye; Xiaoxu Liu; Zongshi Qin; Zhishun Liu
Journal:  BMJ Open       Date:  2015-09-02       Impact factor: 2.692

8.  Prognostic Factors for Chronic Spontaneous Urticaria: A 6-Month Prospective Observational Study.

Authors:  Young Min Ye; Jung Won Park; Sang Ha Kim; Ga Young Ban; Ji Hye Kim; Yoo Seob Shin; Hyun Young Lee; Hae Sim Park
Journal:  Allergy Asthma Immunol Res       Date:  2015-11-10       Impact factor: 5.764

9.  The Effectiveness and Safety of Acupuncture for Patients with Chronic Urticaria: A Systematic Review.

Authors:  Qin Yao; Shanshan Li; Xiaoxu Liu; Zongshi Qin; Zhishun Liu
Journal:  Biomed Res Int       Date:  2016-05-25       Impact factor: 3.411

10.  Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous Urticaria.

Authors:  Jonathan Graham; Doreen McBride; Donald Stull; Anna Halliday; Stamatia Theodora Alexopoulos; Maria-Magdalena Balp; Matthew Griffiths; Ion Agirrezabal; Torsten Zuberbier; Alan Brennan
Journal:  Pharmacoeconomics       Date:  2016-08       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.